Gefitinib for oesophageal cancer progressing after chemotherapy (COG): a phase 3, multicentre, double-blind, placebo-controlled randomised trial

Susan J. Dutton (Lead / Corresponding author), David R. Ferry, Jane M. Blazeby, Haider Abbas, Asa Dahle-Smith, Wasat Mansoor, Joyce Thompson, Mark Harrison, Anirban Chatterjee, Stephen Falk, Angel Garcia-Alonso, David W. Fyfe, Richard A. Hubner, Tina Gamble, Lynnda Peachey, Mina Davoudianfar, Sarah R. Pearson, Patrick Julier, Janusz Jankowski, Rachel KerrRussell D. Petty

    Research output: Contribution to journalArticlepeer-review

    212 Citations (Scopus)

    Search results